Seminars in Nuclear Medicine

Title Publication Date Language Citations
18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation2002/01/01English392
X-ray-based attenuation correction for positron emission tomography/computed tomography scanners2003/07/01English289
Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience2002/04/01English251
Imaging of Neuroendocrine Tumors2006/07/01English241
Positron emission tomography for prostate, bladder, and renal cancer2004/10/01English225
PET imaging in oncology2000/07/01English222
Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings2002/04/01English213
Hypoxia Positron Emission Tomography Imaging With 18F-Fluoromisonidazole2007/11/01English206
Respiratory Motion in Positron Emission Tomography/Computed Tomography: A Review2008/05/01English202
Survival and Response After Peptide Receptor Radionuclide Therapy With [90Y-DOTA0,Tyr3]Octreotide in Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors2006/04/01English196
Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate2001/01/01English193
Positron Emission Tomography as a Diagnostic Tool in Infection: Present Role and Future Possibilities2009/01/01English184
Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging2004/04/01English173
Therapeutic Radionuclides: Biophysical and Radiobiologic Principles2008/09/01English170
Evolution of Tc-99m in diagnostic radiopharmaceuticals2001/10/01English168
Positron emission tomography imaging in nonmalignant thoracic disorders2002/10/01English166
Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies2002/04/01English165
68Ga-labeled DOTA-Peptides and 68Ga-labeled Radiopharmaceuticals for Positron Emission Tomography: Current Status of Research, Clinical Applications, and Future Perspectives2011/07/01English150
Increased 18F-Fluorodeoxyglucose Uptake in Benign, Nonphysiologic Lesions Found on Whole-Body Positron Emission Tomography/Computed Tomography (PET/CT): Accumulated Data From Four Years of Experience With PET/CT2007/05/01English149
Whole-body FDG-PET imaging in the management of patients with cancer2002/01/01English146
Antibody Vectors for Imaging2010/05/01English146
PET/CT scanners: A hardware approach to image fusion2003/07/01English145
111In- and 90Y-DOTA-Lanreotide: Results and implications of the MAURITIUS trial2002/04/01English145
Radionuclide Imaging of the Parathyroid Glands2005/10/01English143
Somatostatin receptor imaging2002/04/01English143
The Clinical Significance of Hypoxia in Human Cancers2015/03/01English143
Functional Imaging of Inflammatory Diseases Using Nuclear Medicine Techniques2009/03/01English142
Positron Emission Tomography/Magnetic Resonance Imaging: The Next Generation of Multimodality Imaging?2008/05/01English137
Positron emission tomography and bone metastases2005/04/01English136
Multimodality Imaging: Beyond PET/CT and SPECT/CT2009/09/01English136